{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:01:32Z","timestamp":1790276492019,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bone.2026.117888","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T17:15:46Z","timestamp":1775495746000},"page":"117888","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Efficacy and safety of Burosumab in tumor-induced osteomalacia: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"208","author":[{"given":"Cain\u00e3 Gon\u00e7alves","family":"Rodrigues","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caio Teotonio","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac Feliciano","family":"de Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Breno Bopp","family":"Antonello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Giovacchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo Victor Zattar","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2026.117888_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2021.116064","article-title":"Challenges in the management of tumor-induced osteomalacia (TIO)","volume":"152","author":"Brandi","year":"2021","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.bone.2026.117888_bb0010","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-11-0006","article-title":"Tumor-induced osteomalacia","volume":"18","author":"Chong","year":"2011","journal-title":"Endocr. Relat. Cancer"},{"issue":"8","key":"10.1016\/j.bone.2026.117888_bb0015","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1002\/jbmr.4620","article-title":"Clinical challenges in diagnosis, tumor localization and treatment of tumor-induced Osteomalacia: outcome of a retrospective surveillance","volume":"37","author":"Hidaka","year":"2020","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.bone.2026.117888_bb0020","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10436","article-title":"Burden of disease in patients with tumor-induced Osteomalacia","volume":"5","author":"Jerkovich","year":"2020","journal-title":"JBMR Plus"},{"issue":"4","key":"10.1016\/j.bone.2026.117888_bb0025","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/jbmr.4233","article-title":"Burosumab for the treatment of tumor-induced osteomalacia","volume":"36","author":"de Beur","year":"2020","journal-title":"J. Bone Miner. Res."},{"issue":"11","key":"10.1016\/j.bone.2026.117888_bb0030","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/jbmr.4900","article-title":"Burosumab improves patient-reported outcomes in adults with tumor-induced osteomalacia: mixed-methods analysis","volume":"38","author":"de Beur","year":"2023","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.bone.2026.117888_bb0035","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/joim.13593","article-title":"Global guidance for the recognition, diagnosis, and management of tumor-induced osteomalacia","volume":"293","author":"de Beur","year":"2022","journal-title":"J. Intern. Med."},{"issue":"2","key":"10.1016\/j.bone.2026.117888_bb0040","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/jbmr.4184","article-title":"Interim analysis of a phase 2 open-label trial assessing Burosumab efficacy and safety in patients with tumor-induced Osteomalacia","volume":"36","author":"Imanishi","year":"2020","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2026.117888_bb0045","article-title":"Updated guidance for trusted systematic reviews: a new edition of the Cochrane handbook for systematic reviews of interventions","volume":"10","author":"Cumpston","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.bone.2026.117888_bb0050","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-076335","article-title":"Updated recommendations for the Cochrane rapid review methods guidance for rapid reviews of effectiveness","volume":"384","author":"Garritty","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.bone.2026.117888_bb0055","series-title":"Assessing Risk of Bias in a Non-randomized Study","first-page":"621","author":"Sterne","year":"2019"},{"issue":"11","key":"10.1016\/j.bone.2026.117888_bb0060","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat. Med."},{"issue":"2","key":"10.1016\/j.bone.2026.117888_bb0065","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/jrsm.1198","article-title":"Comparative performance of heterogeneity variance estimators in meta-analysis: a review of simulation studies","volume":"8","author":"Langan","year":"2016","journal-title":"Res. Synth. Methods"},{"key":"10.1016\/j.bone.2026.117888_bb0070","series-title":"Conducting Meta-Analyses in R with the Metafor Package","author":"Viechtbauer","year":"2010"},{"issue":"10","key":"10.1016\/j.bone.2026.117888_bb0075","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1055\/a-1917-0519","article-title":"Novel therapeutic agents for rare diseases of calcium and phosphate metabolism","volume":"54","author":"Roumpou","year":"2022","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.bone.2026.117888_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.bonr.2024.101772","article-title":"Tumor-induced Osteomalacia: a systematic literature review","volume":"21","author":"\u00c1lvarez-Rivas","year":"2024","journal-title":"Bone Reports"},{"issue":"1","key":"10.1016\/j.bone.2026.117888_bb0085","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.44","article-title":"Tumour-Induced Osteomalacia","volume":"3","author":"Minisola","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"5","key":"10.1016\/j.bone.2026.117888_bb0090","doi-asserted-by":"crossref","first-page":"25","DOI":"10.14341\/probl13221","article-title":"Clinical features, diagnostics and treatment of FGF23 secreting tumors: series of 40 clinical cases","volume":"69","author":"Gronskaia","year":"2023","journal-title":"Probl. Endocrinol."},{"issue":"17","key":"10.1016\/j.bone.2026.117888_bb0095","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1056\/NEJMe030037","article-title":"Oncogenic osteomalacia \u2014 a complex dance of factors","volume":"348","author":"Carpenter","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.bone.2026.117888_bb0100","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00198-022-06516-6","article-title":"Long-term use of burosumab for the treatment of tumor-induced osteomalacia","volume":"34","author":"Crotti","year":"2022","journal-title":"Osteoporos. Int."},{"issue":"6","key":"10.1016\/j.bone.2026.117888_bb0105","doi-asserted-by":"crossref","DOI":"10.1093\/jbmrpl\/ziaf039","article-title":"Real-world efficacy and safety of Burosumab in tumor-induced Osteomalacia: case series from an early access program","volume":"9","author":"Cadiou","year":"2025","journal-title":"JBMR Plus"},{"issue":"1","key":"10.1016\/j.bone.2026.117888_bb0110","doi-asserted-by":"crossref","first-page":"86","DOI":"10.12775\/JEHS.2023.23.01.009","article-title":"Burosumab - new potent treatment for X-linked hypophosphatemia and tumor-induced Osteomalacia","volume":"23","author":"Wojtu\u015b","year":"2023","journal-title":"Journal of Education Health and Sport"},{"key":"10.1016\/j.bone.2026.117888_bb0115","doi-asserted-by":"crossref","DOI":"10.20945\/2359-4292-2023-0242","article-title":"Efficacy and safety of burosumab compared with conventional therapy in patients with X-linked hypophosphatemia: a systematic review","volume":"68","author":"Dodamani","year":"2024","journal-title":"Arch. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.bone.2026.117888_bb0120","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00223-024-01250-z","article-title":"Burosumab efficacy and safety in patients with X-linked hypophosphatemia: systematic review and meta-analysis of real-world data","volume":"115","author":"Kiafzezi","year":"2024","journal-title":"Calcif. Tissue Int."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328226001146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328226001146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T20:30:06Z","timestamp":1784233806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328226001146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":24,"alternative-id":["S8756328226001146"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2026.117888","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of Burosumab in tumor-induced osteomalacia: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2026.117888","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117888"}}